This segment focuses on the discovery, engineering, and manufacturing of high-performance enzymes for various industrial applications. Codexis leverages its CodeEvolver® platform to optimize enzymes for improved activity, stability, and selectivity. Research and development efforts are directed towards expanding the range of chemical reactions that can be catalyzed by enzymes, reducing the environmental impact of manufacturing processes, and lowering production costs. The company's biocatalysts are used in the pharmaceutical, food, and chemical industries, enabling more sustainable and efficient production methods. Future opportunities include expanding into new markets and developing novel enzyme-based solutions for emerging challenges in sustainable manufacturing.

This segment is dedicated to the discovery and development of novel biotherapeutic drug candidates using Codexis's protein engineering expertise. The company's CodeEvolver® platform is employed to engineer enzymes with therapeutic potential, targeting a range of human diseases. Research and development activities include identifying and optimizing enzymes for targeted drug delivery, gene therapy, and other therapeutic applications. Codexis collaborates with pharmaceutical companies to develop innovative enzyme-based therapies for unmet medical needs. The company's therapeutic biocatalysts have the potential to improve patient outcomes and address challenging diseases. Future opportunities include expanding the pipeline of biotherapeutic candidates and advancing clinical trials for promising therapies.